PRAC warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C
Clicca il link per leggere l’articolo http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/12/news_detail_002659.jsp&mid=WC0b01ac058004d5c1